Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2007 4
2008 4
2009 1
2010 4
2011 5
2012 7
2013 11
2014 16
2015 7
2016 7
2017 10
2018 9
2019 17
2020 8
2021 9
2022 6
2023 11
2024 3
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS.
Landgren O, Chari A, Cohen YC, Spencer A, Voorhees PM, Sandhu I, Jenner MW, Smith D, Cavo M, van de Donk NWCJ, Beksac M, Moreau P, Goldschmidt H, Vieyra D, Sha L, Li L, Rousseau E, Dennis R, Carson R, Hofmeister CC. Landgren O, et al. Among authors: hofmeister cc. Blood. 2025 Apr 10;145(15):1658-1669. doi: 10.1182/blood.2024025897. Blood. 2025. PMID: 39652826 Clinical Trial.
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy.
Robinson MH, Villa NY, Jaye DL, Nooka AK, Duffy A, McCachren SS, Manalo J, Switchenko JM, Barnes S, Potdar S, Azeem MI, Horvat AA, Parihar VC, Gong J, Liang Y, Smith GH, Gupta VA, Boise LH, Kaufman JL, Hofmeister CC, Joseph NS, Lonial S, Dhodapkar KM, Dhodapkar MV. Robinson MH, et al. Among authors: hofmeister cc. J Clin Invest. 2023 Aug 1;133(15):e167629. doi: 10.1172/JCI167629. J Clin Invest. 2023. PMID: 37526080 Free PMC article.
Daratumumab in multiple myeloma.
Nooka AK, Kaufman JL, Hofmeister CC, Joseph NS, Heffner TL, Gupta VA, Sullivan HC, Neish AS, Dhodapkar MV, Lonial S. Nooka AK, et al. Among authors: hofmeister cc. Cancer. 2019 Jul 15;125(14):2364-2382. doi: 10.1002/cncr.32065. Epub 2019 Apr 5. Cancer. 2019. PMID: 30951198 Free article. Review.
Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects.
Dona AA, Tandoh T, Nigam L, Singer M, Caserta E, Murtadha M, Zhu Y, Moloudizargari M, Sharma P, Napolitano O, Winchester J, Chowdhury A, Pozhitkov A, Sanchez JF, Vahed H, Marcucci G, Coffey M, Nuovo G, Sborov DW, Pichiorri F, Hofmeister CC. Dona AA, et al. Among authors: hofmeister cc. J Hematol Oncol. 2025 Jan 20;18(1):1. doi: 10.1186/s13045-024-01645-3. J Hematol Oncol. 2025. PMID: 39828738 Free PMC article. Clinical Trial.
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract.
Scott SA, Roberts DL, Gupta VA, Joseph NS, Hofmeister CC, Dhodapkar MV, Lonial S, Nooka AK, Kaufman JL. Scott SA, et al. Among authors: hofmeister cc. Clin Lymphoma Myeloma Leuk. 2025 Sep;25(9):656-660. doi: 10.1016/j.clml.2025.04.002. Epub 2025 Apr 8. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40345961 Free article.
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.
Joseph NS, Kaufman JL, Gupta VA, Hofmeister CC, Dhodapkar MV, Boise LH, DiCamillo SM, Roberts D, Nooka AK, Lonial S. Joseph NS, et al. Among authors: hofmeister cc. Blood Cancer J. 2024 Sep 13;14(1):159. doi: 10.1038/s41408-024-01120-9. Blood Cancer J. 2024. PMID: 39271684 Free PMC article.
The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A, Hofmeister CC, Pichiorri F. Rocci A, et al. Among authors: hofmeister cc. Expert Rev Mol Diagn. 2014 Nov;14(8):947-59. doi: 10.1586/14737159.2014.946906. Epub 2014 Aug 7. Expert Rev Mol Diagn. 2014. PMID: 25098410 Review.
Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy.
Duffy AM, Goenka A, Azeem MI, Taz A, Potdar SV, Scott SA, Marin E, Kaufman JL, Hofmeister CC, Joseph NS, Gupta VA, Lonial S, Nooka AK, Dhodapkar MV, Dhodapkar KM. Duffy AM, et al. Among authors: hofmeister cc. J Clin Invest. 2025 Jul 31;135(19):e192927. doi: 10.1172/JCI192927. eCollection 2025 Oct 1. J Clin Invest. 2025. PMID: 40762835 Free PMC article. No abstract available.
131 results